病理性近视中的脉络膜新生血管：治疗进展
Choroidal neovascularisation in pathological myopia: an update in management.
作者信息
Chan W-M, Ohji M, Lai T Y Y, Liu D T L, Tano Y, Lam D S C
机构信息
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, 3/F, Hong Kong Eye Hospital, Kowloon, Hong Kong.
出版信息
Br J Ophthalmol. 2005 Nov;89(11):1522-8. doi: 10.1136/bjo.2005.074716.
Abstract
Choroidal neovascularisation (CNV) secondary to pathological myopia is an important cause of significant visual impairment in young and middle aged adults globally and is particularly prevalent in Asian populations. In the past few years, there have been rapid advancements in the different treatments for myopic CNV. The purpose of this perspective is to give an overview of the natural history of myopic CNV and the various treatment options including laser photocoagulation, photodynamic therapy, sub-macular surgery, and macular translocation surgery. Future directions in the management of myopic CNV are also discussed.
摘要
病理性近视继发脉络膜新生血管（CNV）是全球中青年严重视力损害的重要原因，在亚洲人群中尤为普遍。在过去几年中，针对近视性CNV的不同治疗方法取得了快速进展。本文旨在概述近视性CNV的自然病程以及包括激光光凝、光动力疗法、黄斑下手术和黄斑转位手术在内的各种治疗选择。还讨论了近视性CNV管理的未来方向。
相似文献
1
Choroidal neovascularisation in pathological myopia: an update in management.病理性近视中的脉络膜新生血管：治疗进展
Br J Ophthalmol. 2005 Nov;89(11):1522-8. doi: 10.1136/bjo.2005.074716.
2
Choroidal Neovascularization Secondary to Myopia, Infection and Inflammation.近视、感染和炎症继发的脉络膜新生血管形成
Dev Ophthalmol. 2016;55:167-75. doi: 10.1159/000431194. Epub 2015 Oct 26.
3
Choroidal neovascularization in pathological myopia.病理性近视中的脉络膜新生血管。
Prog Retin Eye Res. 2012 Sep;31(5):495-525. doi: 10.1016/j.preteyeres.2012.04.001. Epub 2012 Apr 28.
4
Myopic choroidal neovascularisation: current concepts and update on clinical management.近视性脉络膜新生血管：当前概念及临床管理的最新进展
Br J Ophthalmol. 2015 Mar;99(3):289-96. doi: 10.1136/bjophthalmol-2014-305131. Epub 2014 Jul 1.
5
Photodynamic therapy vs limited macular translocation in the management of subfoveal choroidal neovascularization in pathologic myopia: a two-year study.光动力疗法与有限黄斑转位术治疗病理性近视性黄斑下脉络膜新生血管的两年研究
Am J Ophthalmol. 2007 Jan;143(1):68-76. doi: 10.1016/j.ajo.2006.09.041. Epub 2006 Oct 19.
6
Choroidal neovascularization in pathologic myopia: recent developments in diagnosis and treatment.病理性近视中的脉络膜新生血管：诊断与治疗的最新进展
Surv Ophthalmol. 2008 Mar-Apr;53(2):121-38. doi: 10.1016/j.survophthal.2007.12.004.
7
Two-year results of macular translocation with scleral infolding in myopic choroidal neovascularisation.近视性脉络膜新生血管黄斑转位联合巩膜内褶术的两年结果
Semin Ophthalmol. 2004 Mar-Jun;19(1-2):29-42. doi: 10.1080/08820530490520013.
8
Recent trends in the management of maculopathy secondary to pathological myopia.病理性近视性黄斑病变的治疗新进展。
Graefes Arch Clin Exp Ophthalmol. 2012 Jan;250(1):3-13. doi: 10.1007/s00417-011-1889-0. Epub 2011 Dec 13.
9
Myopic maculopathy: a review.近视性黄斑病变：综述。
Ophthalmologica. 2012;228(4):197-213. doi: 10.1159/000339893. Epub 2012 Jul 28.
10
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.光动力疗法联合玻璃体内注射曲安奈德治疗病理性近视继发脉络膜新生血管：一项初步研究。
Br J Ophthalmol. 2007 Feb;91(2):174-9. doi: 10.1136/bjo.2006.103606. Epub 2006 Sep 20.
引用本文的文献
1
Double Myopic Choroidal Neovascular Membranes (CNVMs): A Case Report.双眼近视性脉络膜新生血管膜（CNVMs）：一例报告
Cureus. 2025 Jun 22;17(6):e86567. doi: 10.7759/cureus.86567. eCollection 2025 Jun.
2
Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases.创新型纳米技术在药物输送系统中的应用：用于后节眼部疾病的高级治疗。
Adv Sci (Weinh). 2024 Aug;11(32):e2403399. doi: 10.1002/advs.202403399. Epub 2024 Jun 21.
3
Deep Learning for Diagnosing and Segmenting Choroidal Neovascularization in OCT Angiography in a Large Real-World Data Set.深度学习在大型真实世界数据集的 OCT 血管造影中诊断和分割脉络膜新生血管的应用。
Transl Vis Sci Technol. 2023 Apr 3;12(4):15. doi: 10.1167/tvst.12.4.15.
4
Genetic Polymorphisms in VEGFR Coding Genes (/) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients.VEGFR编码基因的遗传多态性对高度近视和脉络膜新生血管患者雷珠单抗治疗反应的影响
Pharmaceutics. 2022 Jul 26;14(8):1555. doi: 10.3390/pharmaceutics14081555.
5
Angiofluorographic Characteristics of Choroidal Neovascularization associated with Pathologic Myopia.病理性近视相关脉络膜新生血管的血管荧光造影特征。
Rom J Ophthalmol. 2020 Oct-Dec;64(4):356-363. doi: 10.22336/rjo.2020.57.
6
Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patients.阿柏西普治疗近视性脉络膜新生血管患者的初步研究。
BMC Ophthalmol. 2020 Oct 19;20(1):414. doi: 10.1186/s12886-020-01679-4.
7
OLIMPIC: a 12-month study on the criteria driving retreatment with ranibizumab in patients with visual impairment due to myopic choroidal neovascularization.OLIMPIC：一项为期12个月的研究，关于驱动因近视性脉络膜新生血管导致视力损害的患者再次使用雷珠单抗治疗的标准。
Graefes Arch Clin Exp Ophthalmol. 2019 Apr;257(4):759-768. doi: 10.1007/s00417-019-04248-8. Epub 2019 Jan 24.
8
RANIBIZUMAB VERSUS VERTEPORFIN PHOTODYNAMIC THERAPY IN ASIAN PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION: BRILLIANCE, a 12-Month, Randomized, Double-Masked Study.雷珠单抗与维替泊芬光动力疗法治疗亚洲近视脉络膜新生血管患者的疗效比较：BRIGHTNESS 研究，一项 12 个月、随机、双盲研究。
Retina. 2019 Oct;39(10):1985-1994. doi: 10.1097/IAE.0000000000002292.
9
Fluorescein Leakage within Recent Subretinal Hemorrhage in Pathologic Myopia: Suggestive of CNV?病理性近视近期视网膜下出血内的荧光素渗漏：提示脉络膜新生血管？
J Ophthalmol. 2018 Aug 13;2018:4707832. doi: 10.1155/2018/4707832. eCollection 2018.
10
Context-dependent compensation among phosphatidylserine-recognition receptors.磷脂酰丝氨酸识别受体的语境相关补偿。
Sci Rep. 2017 Nov 7;7(1):14623. doi: 10.1038/s41598-017-15191-1.
本文引用的文献
1
Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.玻璃体内注射雷珠单抗联合维替泊芬光动力疗法治疗猴实验性脉络膜新生血管的安全性和有效性
Arch Ophthalmol. 2005 Apr;123(4):509-16. doi: 10.1001/archopht.123.4.509.
2
Pegaptanib for neovascular age-related macular degeneration.培加他尼用于治疗新生血管性年龄相关性黄斑变性。
N Engl J Med. 2004 Dec 30;351(27):2805-16. doi: 10.1056/NEJMoa042760.
3
Two-year results of macular translocation with scleral infolding in myopic choroidal neovascularisation.近视性脉络膜新生血管黄斑转位联合巩膜内褶术的两年结果
Semin Ophthalmol. 2004 Mar-Jun;19(1-2):29-42. doi: 10.1080/08820530490520013.
4
Prevalence of refractive errors in a rural South Indian population.印度南部农村人口屈光不正的患病率。
Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4268-72. doi: 10.1167/iovs.04-0221.
5
Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.维替泊芬光动力疗法治疗中国患者病理性近视性黄斑下脉络膜新生血管：一项为期1年和2年随访的前瞻性研究。
Br J Ophthalmol. 2004 Oct;88(10):1315-9. doi: 10.1136/bjo.2004.041624.
6
Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia-1-year results of a prospective series.维替泊芬光动力疗法治疗病理性近视继发的近黄斑中心凹脉络膜新生血管——一项前瞻性系列研究的1年结果
Eye (Lond). 2005 Aug;19(8):834-40. doi: 10.1038/sj.eye.6701681.
7
Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia.影响病理性近视性黄斑下脉络膜新生血管光动力疗法视觉预后的预后因素。
Am J Ophthalmol. 2004 Sep;138(3):434-8. doi: 10.1016/j.ajo.2004.04.055.
8
Characteristics of patients with a favorable natural course of myopic choroidal neovascularization.近视性脉络膜新生血管自然病程良好患者的特征。
Graefes Arch Clin Exp Ophthalmol. 2005 Jan;243(1):13-9. doi: 10.1007/s00417-004-0960-5. Epub 2004 Jul 28.
9
Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation in pathologic myopia.维替泊芬光动力疗法治疗病理性近视性黄斑中心凹外脉络膜新生血管
Graefes Arch Clin Exp Ophthalmol. 2004 Nov;242(11):926-30. doi: 10.1007/s00417-004-0949-0. Epub 2004 Jul 17.
10
Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy.光动力疗法后多焦视网膜电图显示视网膜功能的短暂降低。
Am J Ophthalmol. 2004 May;137(5):826-33. doi: 10.1016/j.ajo.2003.11.079.
Zotero 插件